We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.04B
AUM Growth
+$368M
Cap. Flow
+$68.3M
Cap. Flow %
1.69%
Top 10 Hldgs %
14.84%
Holding
1,360
New
108
Increased
584
Reduced
484
Closed
87

Top Buys

Rank Stock Value
1
DOCU
DocuSign
DOCU
+$4.67M
2
ADBE icon
Adobe
ADBE
+$4.33M
3
PWR icon
Quanta Services
PWR
+$3.93M
4
SPYD icon
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
+$3.61M
5
BMY icon
Bristol-Myers Squibb
BMY
+$3.61M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.53M
2
AAPL icon
Apple
AAPL
+$5.68M
3
IHI icon
iShares US Medical Devices ETF
IHI
+$4.6M
4
IYC icon
iShares US Consumer Discretionary ETF
IYC
+$4.11M
5
STZ icon
Constellation Brands
STZ
+$3.98M

Sector Composition

Rank Sector Weight
1 Technology 14.02%
2 Healthcare 12.17%
3 Financials 11.29%
4 Consumer Discretionary 8.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDS.A
251
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3.77M 0.09%
63,864
+1,001
+2% +$58.5K
CPB icon
252
Campbell Soup
CPB
$6.87B
$3.76M 0.09%
76,131
-4,096
-5% -$194K
MLP icon
253
Maui Land & Pineapple Co
MLP
$344M
$3.75M 0.09%
333,760
+9,762
+3% +$104K
FVD icon
254
First Trust Value Line Dividend Fund
FVD
$8.4B
$3.75M 0.09%
103,976
+34,349
+49% +$1.21M
BIIB icon
255
Biogen
BIIB
$30.7B
$3.73M 0.09%
12,558
-182
-1% -$50.5K
CHKP icon
256
Check Point Software Technologies
CHKP
$13.1B
$3.72M 0.09%
33,531
-1,517
-4% -$170K
USMV icon
257
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
$3.7M 0.09%
56,454
+8,681
+18% +$558K
IJS icon
258
iShares S&P Small-Cap 600 Value ETF
IJS
$8.37B
$3.68M 0.09%
45,734
+9,520
+26% +$738K
VMW
259
DELISTED
VMware, Inc
VMW
$3.67M 0.09%
24,191
-1,629
-6% -$255K
REGN icon
260
Regeneron Pharmaceuticals
REGN
$80.8B
$3.66M 0.09%
9,741
+2,508
+35% +$844K
RSP icon
261
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$3.64M 0.09%
31,460
-1,401
-4% -$156K
CL icon
262
Colgate-Palmolive
CL
$74.4B
$3.62M 0.09%
52,612
-3,408
-6% -$232K
ABB
263
DELISTED
ABB Ltd
ABB
$3.58M 0.09%
148,544
-2,615
-2% -$56K
ES icon
264
Eversource Energy
ES
$27.2B
$3.52M 0.09%
41,425
+79
+0.2% +$6.57K
NEAR icon
265
iShares Short Maturity Bond ETF
NEAR
$4.88B
$3.51M 0.09%
69,797
+4,347
+7% +$219K
DG icon
266
Dollar General
DG
$27.9B
$3.5M 0.09%
22,469
+4,425
+25% +$702K
CLF icon
267
Cleveland-Cliffs
CLF
$6.99B
$3.48M 0.09%
413,936
+72,651
+21% +$558K
GDX icon
268
VanEck Gold Miners ETF
GDX
$27.4B
$3.47M 0.09%
118,464
+25,571
+28% +$699K
GSK icon
269
GSK
GSK
$106B
$3.46M 0.09%
58,898
+2,125
+4% +$118K
XLI icon
270
State Street Industrial Select Sector SPDR ETF
XLI
$34.6B
$3.44M 0.09%
42,227
+20,279
+92% +$1.62M
KMB icon
271
Kimberly-Clark
KMB
$36.5B
$3.43M 0.08%
24,910
+275
+1% +$37.2K
MKC icon
272
McCormick & Company Non-Voting
MKC
$14.2B
$3.4M 0.08%
40,042
+1,100
+3% +$91K
GDV icon
273
Gabelli Dividend & Income Trust
GDV
$2.66B
$3.38M 0.08%
153,899
+17,895
+13% +$375K
PLD icon
274
Prologis
PLD
$133B
$3.36M 0.08%
37,721
-1,145
-3% -$101K
CQQQ icon
275
Invesco China Technology ETF
CQQQ
$3.31B
$3.36M 0.08%
63,908
+26,923
+73% +$1.33M
9 10
11
12 13

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Oppenheimer & Co held 1,360 positions worth $4.04B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q4 2019 filing shows 108 new, 584 increased, 484 reduced and 87 closed positions. Its largest new stake was CAE Inc. Common Shares: 78,310 shares worth $2.07M. The largest sale was Celgene Corp, an estimated $6.53M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q4 2019 buy was CAE Inc. Common Shares: 78,310 shares worth $2.07M.
  • Oppenheimer & Co added most to DocuSign in Q4 2019, an estimated $4.67M increase.
  • Oppenheimer & Co's biggest Q4 2019 reduction was Apple, cutting an estimated $5.68M.
  • Oppenheimer & Co fully exited Celgene Corp in Q4 2019, selling an estimated $6.53M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $4.04B portfolio in Q4 2019.
  • Oppenheimer & Co opened 108 new positions and closed 87 in Q4 2019.
  • Oppenheimer & Co's portfolio value rose 10% quarter-over-quarter to $4.04B.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.